Drug Profile
SIV vaccine
Alternative Names: SIVdelta3Latest Information Update: 16 Oct 2007
Price :
$50
*
At a glance
- Originator Endocon; Institut Pasteur
- Developer Chiron Corporation; Endocon; Harvard Medical School; National Institutes of Health (USA); New England Regional Primate Center; Nonindustrial source; TSI Mason Laboratories; University of California, Davis
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections